Neo-lubrina Children Syrup
Product Images NDC 69729-827

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Neo-lubrina Children (NDC 69729-827). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Opmx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Directions (Neolubrina Directions)

Directions (Neolubrina Directions)
The text provides information on recommended dosage for individuals under 2 years old and weighing less than 24 pounds. It suggests consulting a doctor for more guidance on the appropriate dose in such cases.*
FDA Label Image

Bottle (Neo Lubrina Children Bottle)

Bottle (Neo Lubrina Children Bottle)
FDA Label Image

Pdp1 (Neo Lubrina Pdp)

Pdp1 (Neo Lubrina Pdp)
This is a detailed description of Neo-Lubrina Children's Acetaminophen Oral Suspension, providing information on the dosage, purpose, directions for use, warnings, and active ingredients. The product is designed to provide quick relief of fever and pain in children aged 2 weeks and above. It contains 160 mg of acetaminophen per 5 mL and is cherry-flavored. The text also includes important warnings such as liver damage risks, overdose warnings, and advice to consult a doctor in case of specific symptoms or conditions. The directions for use are based on weight and age, with a recommended dose every 4 hours. The text also lists the inactive ingredients and provides contact information for further inquiries.*
FDA Label Image

Esp (Tdf Neolubrina Esp)

Esp (Tdf Neolubrina Esp)
This is a medication label with information on uses, warnings, dosage, and ingredients of a product containing acetaminophen. It provides guidance on managing minor aches, pains, and fevers. The text also includes recommendations for different age groups based on weight and age. It emphasizes the importance of consulting a healthcare professional before use, especially for those with allergies, liver conditions, or taking other medications. The label also warns against exceeding the recommended dose and offers instructions in case of overdose. Additional details cover storage instructions and inactive ingredients of the product.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.